In Brief Beckervordersandforth, Ebert et al. demonstrate that mitochondrial complex function functionally demarcates an early developmental step in adult hippocampal neurogenesis and identify mitochondrial dysfunction as a candidate target to counter age-associated neurogenesis deficits.
SUMMARY
Precise regulation of cellular metabolism is hypothesized to constitute a vital component of the developmental sequence underlying the life-long generation of hippocampal neurons from quiescent neural stem cells (NSCs) . The identity of stage-specific metabolic programs and their impact on adult neurogenesis are largely unknown. We show that the adult hippocampal neurogenic lineage is critically dependent on the mitochondrial electron transport chain and oxidative phosphorylation machinery at the stage of the fast proliferating intermediate progenitor cell. Perturbation of mitochondrial complex function by ablation of the mitochondrial transcription factor A (Tfam) reproduces multiple hallmarks of aging in hippocampal neurogenesis, whereas pharmacological enhancement of mitochondrial function ameliorates age-associated neurogenesis defects. Together with the finding of age-associated alterations in mitochondrial function and morphology in NSCs, these data link mitochondrial complex function to efficient lineage progression of adult NSCs and identify mitochondrial function as a potential target to ameliorate neurogenesis-defects in the aging hippocampus.
INTRODUCTION
Quiescent radial glia-like neural stem cells (NSCs) in the rodent hippocampal dentate gyrus (DG) give rise to neurons throughout life. It is now well accepted that a substantial number of new neurons is also generated in the DG of adult humans (Eriksson et al., 1998; Spalding et al., 2013) . New neurons fulfill important functions in hippocampal plasticity and it is hypothesized that impaired neurogenesis contributes to the pathophysiology of cognitive symptoms in aging and neuropsychiatric diseases (Abrous and Wojtowicz, 2015; Christian et al., 2014; Rolando and Taylor, 2014) .
Neurogenesis from a quiescent radial glia-like NSC is achieved through a stereotypic developmental sequence controlled by the interplay of neurogenic niche-derived signals with intracellular pathways (Bond et al., 2015) . To date, studies have largely focused on developmental signaling, transcriptional, and epigenetic pathways to understand how the neurogenic sequence is regulated (Aimone et al., 2014) .
En route to its differentiation into a mature neuron, the quiescent NSC undergoes extensive changes in proliferative activity, cellular growth, and synaptic activity (Shin et al., 2015) . These changes are likely to impose distinct demands on the availability of energy equivalents and precursors for anabolic pathways. The discovery that a metabolic shift toward de novo lipogenesis is required for the activation of quiescent NSCs and NSC proliferation provided the first direct evidence that lineage progression in adult hippocampal neurogenesis is functionally coupled to the activity of a specific metabolic program (Knobloch et al., 2013) . The questions whether the adult neurogenic sequence (D) Quantification of the average mitochondrial volume revealed that mitochondria in newborn neurons are larger than in NSCs and IPCs. Though mitochondria of newborn neurons appear small in cross-sections, their volumes are much larger due to their wider and highly elongated morphology (see also Movies S1, S2, and S3). The average mitochondrial volume in NSCs and IPCs is comparable with the exception of mitochondria in the primary process of NSCs (primary process, pp; fine process, fp; cell body, cb). (E) Statistics of the comparative analysis of mitochondrial volume measurements.
(legend continued on next page)
is defined by developmental stage-specific metabolic codes, and whether metabolic programs constrain further steps in adult neurogenesis, remain unresolved.
Quiescent radial glia-like NSCs share many characteristics of astrocytes (Rolando and Taylor, 2014) , which have a predominantly glycolytic profile (Bé langer et al., 2011; Hamberger and Hyden, 1963; Hyden and Lange, 1962) . Notably, recent studies indicated that highly proliferative embryonic neural precursors are glycolytic (Agathocleous et al., 2012; Homem et al., 2014; Khacho et al., 2016; Zheng et al., 2016) . In contrast, functionally integrated neurons are highly dependent on the mitochondrial electron transport chain (ETC) and oxidative phosphorylation (oxPhos) (Hall et al., 2012) to meet their high-energy requirements imposed in particular by presynaptic vesicle recycling, and by the recurrent generation of action potentials and postsynaptic potentials (Alle et al., 2009; Attwell and Laughlin, 2001) . If and when a metabolic program involving ETC and oxPhos function becomes critical during in vivo mammalian neurogenesis in general, and in adult hippocampal neurogenesis in particular, remains unknown. Here, we made the surprising observation that integrity of the ETC and oxPhos machinery is critical already during the earliest stages of adult hippocampal neurogenesis long before the stage of synaptic integration of newborn neurons. Using pharmacologic and genetic approaches, we show that ETC and oxPhos function are critical for proliferation and survival of intermediate progenitor cells (IPCs) generated by activated NSCs. Moreover, we found evidence that impaired mitochondrial function contributes to age-associated decline in hippocampal neurogenesis and observed that pharmacological enhancement of mitochondrial function promotes neurogenesis in the aging hippocampus. Collectively, the present data identify activity of the ETC and oxPhos machinery as a critical determinant of adult hippocampal neurogenesis and indicate mitochondrial function as a candidate target to ameliorate age-associated neurogenesis deficits.
RESULTS
Increased mitochondrial mass and size are considered structural correlates of higher ETC and oxPhos activity (Alirol and Martinou, 2006) . Ultra-structural analysis using electron microscopy revealed that mitochondria in adult hippocampal radial glia-like NSCs were of mixed globular and tubular shape ( Figure 1A and Movie S1). In comparison, mitochondria in IPCs displayed a thin and more elongated shape ( Figure 1B and Movie S2), while mitochondria in mature adult-born dentate granule neurons featured a wider and highly elongated morphology ( Figure 1C and Movie S3). Mitochondria in different compartments of NSCs and IPCs were of comparable volume with the exception of mitochondria in the radial process of NSCs, which were slightly larger ( Figures 1D and 1E) . Consistent with the longstanding notion that mature neurons are heavily reliant on ETC and oxPhos activity (Bé langer et al., 2011) , and with the recent in vitro and ex vivo evidence that proliferating neural progenitor cells show high levels of aerobic glycolysis (Agathocleous et al., 2012; Homem et al., 2014; Khacho et al., 2016; Zheng et al., 2016) , mitochondria in neurons were significantly more voluminous than mitochondria in NSCs and IPCs ( Figures 1D  and 1E ).
Using cultured adult neural stem/progenitor cells (NSPCs), we found that mitochondrial membrane potential, measured using rhodamine 123, did not significantly differ between BMP4-induced quiescent NSPCs (Martynoga et al., 2013; Mira et al., 2010) and proliferating NSPCs ( Figure 1F ). In line with recent in vitro analyses of embryonic NSPCs (Khacho et al., 2016; Zheng et al., 2016) , neuronally differentiated NSPCs displayed a significantly increased mitochondrial membrane potential compared to proliferating NSPCs (data not shown) indicating higher ETC and oxPhos activity in NSPC-derived neurons.
To gain further insight into the timing of increased ETC and oxPhos activity during the generation of neurons from radial glialike NSCs in vivo, we analyzed gene expression datasets from the adult hippocampal neurogenic lineage with a focus on genes linked to metabolism. Counter to the mitochondrial morphology and membrane potential measurements, in-depth analysis of a resource describing the transcriptomic dynamics during the early phases of adult hippocampal neurogenesis (Shin et al., 2015) indicated an unexpected increase of ETC and oxPhos activity already in the early neurogenic lineage ( Figures 1G-1J , and Figure S1 ). Upregulation of cell-cycle genes reflected the activation of quiescent NSCs and the increasing proliferative activity along the early neurogenic lineage ( Figure S1A ). Transcriptomic signatures suggested beta-oxidation and glycolysis as energyproviding metabolic circuits in quiescent and activated NSCs ( Figures 1H and 1J) . Downregulation of the NSC marker Fabp7 (Lugert et al., 2010; Steiner et al., 2006) and expression of the IPC marker Tbr2 (Hodge et al., 2012) were paralleled by upregulation of enzymes of the tricarboxylic acid (TCA) cycle ( Figure 1J ), which provides electron carriers to the ETC, and upregulation of components of the mitochondrial (mt) complexes, (F) In vitro quiescent NSPCs (BMP4-silenced as described in STAR Methods) exhibit a membrane potential comparable to the membrane potential of proliferating NSPCs. (G) Scheme of the GO enrichment analysis of the transcriptomic database described in (Shin et al., 2015) . The total genes in the genome were first divided into three groups based on their trend along pseudotime progression. The proportion of up and down genes in each GO entity of interest was surveyed to evaluate the functional directionality of the GO entity during progression of early adult neurogenesis. (H) Proportion of upregulated and downregulated genes within key functional GO entities (see also Figure S1A ). Note the upregulation of ETC and mitochondrial complex associated genes. (I) Schematic drawing of the hippocampal NSC lineage with stage-specific expression of molecular markers. Box indicates developmental stages covered by transcriptomic resource. (J) Violin diagrams depict lineage progression of quiescent NSCs (qNSCs; aNSC, activated neural stem cell) to IPCs as evidenced by downregulation of Fapb7 and concomitant upregulation of Tbr2. Note the downregulation of genes associated with glycolysis and upregulation of genes associated with the TCA cycle and oxPhos. S1-S5 represent developmental stages ordered along pseudotime progression. Data in (D) and (F) represented as mean ± SEM; t test was performed to test significance in membrane potential (F). which are the structural prerequisites for ETC and oxPhos (Figures 1H and 1J) . Most notably, genes related to mt complex V, i.e., the key enzymatic complex for mitochondrial ATP production/oxPhos, showed consistent upregulation during early lineage progression (Figures S1B-S1G ). In contrast, key enzymes in glycolysis such as aldolase A and lactate dehydrogenase A, and the mitochondrial uncoupling protein 2 (UCP2), which was recently implied in promoting aerobic glycolysis over oxPhos in embryonic neural precursor cells (Khacho et al., 2016; Zheng et al., 2016) , were downregulated around the time of NSC activation ( Figures S1H-S1K ). Collectively, these results predicted a metabolic shift involving increased activity of ETC and oxPhos around the time of transition from activated NSCs to IPCs.
To test the functional relevance of the ETC and oxPhos machinery in the early neurogenic lineage, we interrupted ETC and oxPhos activity in NSPC cultures using rotenone, which inhibits the transfer of electrons from mt complex I to the electron carrier ubiquinone, and oligomycin, which inhibits mt complex V and thus oxPhos. NSPCs were treated with either compound for 24 hr prior to analysis. Both rotenone and oligomycin treatment reduced mitochondrial membrane potential to approximately 50% of control levels, demonstrating that NSPCs harbored a functional ETC (Figure 2A ). Moreover, rotenone treatment significantly reduced ATP production, whereas oligomycin treatment almost completely blocked ATP production ( Figure 2B ). Most importantly, both treatments abolished cell proliferation (Figure 2C ) and led to an approximately 5-fold increase in cell death ( Figure 2D ). These results revealed that proliferating NSPCs are highly dependent on functional ETC and oxPhos.
Next, we genetically disrupted mitochondrial ETC and oxPhos activity in NSPCs by conditional ablation of the mitochondrial transcription factor A (Tfam) (Larsson et al., 1998) . Tfam is required for expression of key components of the mt complexes. As a consequence, ablation of Tfam produces profound dysfunction of the ETC and the oxPhos machinery (Larsson et al., 1998 Figure 2H ) and a substantial impairment in cell viability ( Figure 2I) (Ekstrand et al., 2007; Silva et al., 2000; Sö rensen et al., 2001; Wang et al., 1999 Figure S2B ). In contrast, HSP60 + mitochondria in recombined cells of control mice were invariably positive for Cox1 (Figures 2J and 2L) . In addition, many recombined cells in Tfam cko mice harbored mitochondria that showed increased HSP60-immunoreactivity and displayed an aberrant clumpy morphology (Figures 2K and 2M Figure S2D ). Long-term BrdU pulse-chase experiments (3 days pulse of BrdU at the age of 2 months, 2 months chase), however, revealed that cells generated at the age of 2 months were severely impaired in their long-term survival ( Figure S2E ). Moreover, 4-month-old Tfam cko mice exhibited a pronounced proliferation deficit in the DG (Figures 3A, 3B, and 3F; Figure S2F ). Using distinct histological markers for different precursor populations ( Figure 1I ), we performed quantitative analysis to determine whether Tfam deficiency impaired neurogenesis at a specific Figure 2I ) and that BMP4-induced quiescence resulted in a trend toward higher viability of Tfam-deficient NSPCs (p = 0.066) ( Figure S2G ) suggests that the increase in apoptotic cells was caused in part by programmed cell death of proliferating progenitors. We also investigated whether mitochondrial dysfunction induced by Tfam deletion impeded later developmental stages, in particular, neuronal growth. To this end, Tfam loxP/loxP mice were stereotaxically injected with a recombinant MMLV bi-cistronically encoding for GFP and Cre-recombinase to induce Tfam deletion starting around the stage of IPCs and neuroblasts (Tashiro et al., 2006) . Tfam loxP/loxP mice injected with an MMLV encoding for GFP served as controls. Tfam-ablated neurons displayed mildly shortened dendritic length and decreased dendritic complexity at 90 days post-viral injection ( Figures 3N-3P ). These observations indicate that impairment of the ETC or oxPhos machinery compromised growth and maturation of adult-born neurons, which lends support to the recent suggestion that precise regulation of mitochondrial metabolism is required for the morphological and functional development of adult-born neurons (Oruganty-Das et al., 2012; Steib et al., 2014) . Mitochondrial dysfunction is postulated to contribute to organismal aging (Ló pez-Otín et al., 2013); its impact on ageassociated impairment of hippocampal neurogenesis, however, remains undetermined. Analysis of young (4-month-old) and middle-aged (1-year-old) mice confirmed the previously described age-associated neurogenesis deficit (Drapeau and Nora Abrous, 2008) : thus, middle-aged mice revealed a severe cell proliferation deficit ( Figures S4A, S4B , and S4D) and showed a pronounced (i.e., up to 10-fold) decrease in the number of radial glia-like NSCs, activated NSCs, IPCs, and DCX + neuroblasts and immature neurons ( Figures S4C and S4E-S4H ).
To extend the insight into how aging impacts on the adult neurogenic lineage and on the transition between developmental stages, we calculated the lineage progression index ( Figure 4A ). The proportion of activated NSCs among NSCs was comparable between young and middle-aged animals. In contrast, the ratio of IPCs to activated NSCs was greatly reduced in older animals (Figure 4A) , suggesting that aging impedes on neurogenic lineage progression at the level of generation of the highly proliferative IPC population. In line with a recent report (Seib et al., 2013) , immature DCX + neurons in older mice bore only short processes that mostly terminated at the border between granule cell layer and molecular layer ( Figure S4C ). To extend the knowledge on the impact of aging on dendritic development, we compared the morphology of mature (i.e., 2-month-old) neurons generated in young and middle-aged mice using an MMLV encoding for GFP. As a consequence of the age-dependent decrease in proliferation activity, we were unable to efficiently label adult-born neurons in 1-year-old animals. We therefore opted to visualize DG neurons generated in 8-month-old mice and to compare their morphology to their counterparts generated in 2-month-old mice. Neurons generated in older mice bore a shorter and less complex dendritic tree compared to neurons generated in young animals ( Figures 4B-4D ), indicating that aging impacts on dendritic growth and results in a persistent dendritic morphology deficit. The similarities between age-dependent alterations of the NSC lineage and the Tfam cko mice phenotype (i.e., proliferation deficit, decreased generation of new neurons, lineage progression deficit at the transition from activated NSCs to IPCs, but not the loss of radial glia-like NSCs), prompted us to search for evidence of ageassociated mitochondrial dysfunction in the adult hippocampal neurogenic lineage. All radial glia-like NSCs and IPCs in young mice (4 months) and middle-aged mice (1 year) contained Cox + mitochondria. Intriguingly, HSP60-based morphological evaluation of mitochondria revealed that in contrast to radial glia-like NSCs in 4-month-old mice ( Figure 4E ), around one-third (34%) of the NSC population in 1-year-old mice harbored (Table S1 ). Data represented as mean ± SEM; t test was performed to determine significance; all scale bars = 20 mm.
densely packed mitochondria of clumpy appearance in their radial process ( Figure 4F ). IPCs in 1-year-old mice did not display obvious alterations in mitochondrial morphology ( Figures S4I and  S4J) ; the elongated morphology of mitochondria in IPCs (Figure 1B) , however, may have masked alterations in mitochondrial morphology such as mitochondrial clumping. Next, we sought to compare mitochondrial function NSPCs from young and middle-aged mice. Notably, we were unable to consistently establish NSPC cultures from the dissected hippocampus of 1-year-old mice, most likely because of the age-associated low number and impaired proliferative capacity of NSPCs in the hippocampal neurogenic niche. In analogy to hippocampal neurogenesis, neurogenic activity in the main neurogenic niche of the rodent forebrain, i.e., the subependymal zone (SEZ) of the lateral ventricles, is greatly impaired during aging (Shook et al., 2012) . Compared to the hippocampal DG, the SEZ harbors (Table S1 ). Data presented as mean ± SEM; t test was performed to determine significance; scale bars = 10 mm.
greater numbers of NSPCs and thus allowed us to establish NSPC cultures from 1-year-old mice to investigate age-associated alterations to mitochondrial function in NSPCs. In line with a recent report of age-associated defective oxidative metabolism in forebrain-derived NSPCs (Perry et al., 2011; Stoll et al., 2011) , we found that age-dependent proliferation deficits were accompanied by decreased mitochondrial membrane potential and lower levels of ATP (Figures 4G-4I) .
Collectively, these findings suggested that mitochondrial dysfunction contributes to diminished hippocampal neurogenesis during aging and raised the intriguing possibility that enhancement of mitochondrial function may improve neurogenesis during aging. The nootropic compound piracetam is used for the treatment of age-related cognitive impairment and dementia (Waegemans et al., 2002) and was found to enhanceamong other mitochondrial parameters-mitochondrial respiration, ETC activity, and ATP production in particular in cells with compromised mitochondrial function (Costa et al., 2013; Keil et al., 2006; Kurz et al., 2010; Leuner et al., 2010; Stockburger et al., 2013; Zhang et al., 2010) . Piracetam treatment of NSPCs derived from 1-year-old mice resulted in a trend toward increased proliferation, which was paralleled by a significant increase in ATP production in the absence of changes in mitochondrial membrane potential ( Figures 5A-5C ). To investigate whether piracetam-induced enhancement of NSPC proliferation depended on the integrity of the ETC and/or oxPhos machinery, we first analyzed the effects of piracetam on Tfam-deficient NSPCs. While piracetam treatment did not alter ATP production, it surprisingly increased mitochondrial membrane potential (Figures S5A and S5B) , suggesting that Tfam-deficient NSPCs harbored residual function of mitochondrial complexes, which could be enhanced by piracetam treatment. Interestingly, we also observed a piracetam-induced increase in proliferation of Tfam-deficient GFP-reporter + NSPCs ( Figure S5C ). Because these results did not provide unequivocal insight into the requirement of a functional ETC and oxPhos machinery for piracetam-induced enhancement of proliferation, we tested the effects of piracetam in the context of rotenone-and oligomycin-induced inhibition of the ETC and oxPhos machinery. Treatment with piracetam neither increased mitochondrial membrane potential nor ATP production ( Figures S5D-S5F ). Most importantly, piracetam did not ameliorate the proliferation defect of rotenone-and oligomycin-treated cultures as evidenced by the complete absence of BrdU incorporating NSPCs, suggesting that piracetam-induced enhancement of NSPC proliferation is dependent on the amelioration of mitochondrial dysfunction and requires residual ETC and oxPhos activity.
Finally, we investigated piracetam's potential to ameliorate age-associated hippocampal neurogenesis defects. To this end, 18-month-old mice received a daily oral dose of piracetam for 14 days; control mice received a corresponding dose of the solvent. Animals were perfused 1 day after the last dose ( Figure 5D ). Immunostainings of the DG using HSP60 and an antibody cocktail that recognizes components of mt complexes I-V showed that piracetam treatment resulted in a more homogeneous expression of mt complexes I-V in HSP60 + mitochondria.
Moreover, we occasionally observed in untreated animals radial glia-like GFAP + cells that contained mitochondria with an aberrant clumpy morphology, which appeared to be less frequent in piracetam-treated animals ( Figure 5E Figure 5L ). Moreover, we observed that DCX + neurons in piracetam-treated mice displayed a higher total dendritic length and a more complex dendritic morphology ( Figures  5M-5O ) and extended dendrites deep into molecular cell layer similar to newborn neurons in the young brain ( Figure 5G ). These results demonstrate that piracetam improved age-associated hippocampal neurogenesis defects. It is, however, important to point out that piracetam did not restore neurogenesis to levels observed in young mice (compare Figures 3J and 5K for numbers of DCX + newborn neurons), which may reflect the multifactorial cause of age-associated neurogenesis defects as well as the pronounced depletion of radial glia-like NSCs in the hippocampus of aged mice.
DISCUSSION
Here, we provide in vivo functional genetic evidence supported by gene expression profiling that the adult hippocampal neurogenic lineage is critically dependent on mitochondrial complex function at the level of IPCs. Thus, our data strongly support the emerging notion that stage-specific metabolic programs are functionally linked to distinct developmental steps within the NSC lineage (Beckervordersandforth et al., 2015; Folmes et al., 2012; Knobloch and Jessberger, 2015; Rafalski and Brunet, 2011; Yeo et al., 2013) . Recent reports indicated that highly proliferating embryonic neural stem and progenitor cells are glycolytic and that high oxPhos activity is associated with termination of proliferation and neuronal differentiation (Agathocleous et al., 2012; Homem et al., 2014; Khacho et al., 2016; Zheng et al., 2016) . Thus, our finding that mitochondrial complex function is already required in the highly proliferative IPC population was unexpected. Very recent in vitro studies indicated that cancer cells require ETC function to regenerate electron acceptors for the biosynthesis of the limiting amino acid aspartate in order to sustain high levels of proliferation (Birsoy et al., 2015; Sullivan et al., 2015) . Another intriguing possibility would be that mitochondrial complexes are required to generate reactive oxygen species, which have recently been described to regulate embryonic NSPC proliferation (Forsberg et al., 2013; Hou et al., 2012; Khacho et al., 2016) . It will be interesting to determine whether IPCs require only a functional ETC or both ETC and oxPhos activity and which Figure S3 ). Moreover, in vitro analysis demonstrated that Tfam deficiency directly affected proliferation and survival in NSPC cultures, which are largely devoid of astrocytes. We would therefore argue that the neurogenesis defects in Tfam cko mice are to a significant extent the result of Tfam deficiency in the neurogenic lineage. Nevertheless, the specific impact of astrocytic Tfam deletion on neurogenesis should be investigated in the future. Decreased hippocampal neurogenesis is a common hallmark of mammalian aging (Kempermann et al., 1998; Kuhn et al., 1996; Spalding et al., 2013) . It has been suggested that the neurogenesis phenotype during aging is caused by a combination of systemic and cell-intrinsic aging factors (Katsimpardi et al., 2014; Molofsky et al., 2006; Smith et al., 2015) . The precise mechanisms and the identity of contributing factors underlying the age-associated impairment in hippocampal neurogenesis remain, however, largely unknown. Mitochondrial dysfunction was previously proposed as a major contributing factor to ageassociated neurogenesis deficits (Ahlqvist et al., 2012; Cheng et al., 2010; Stoll et al., 2011 Stoll et al., , 2015 . Such connection remained speculative, as published animal models for mitochondrial dysfunction failed to reproduce the severe proliferation and neurogenesis defects found during aging (Ahlqvist et al., 2012) . Our findings that Tfam ablation in NSCs phenocopies key aspects of aging, that aging is associated with altered mitochondrial load and the appearance of morphologically abnormal mitochondria in radial glia-like NSCs, and that pharmacological enhancement of mitochondrial function promotes hippocampal neurogenesis in aged animals provide evidence for mitochondrial dysfunction as a key contributor to age-associated impairment of hippocampal neurogenesis.
Aging is also a major negative regulator of neurogenic activity in the SEZ of the lateral ventricles (Shook et al., 2012) . It will be important to establish to which extent the neurogenic lineages of the SEZ/olfactory bulb system and of the hippocampus are controlled by overlapping metabolic programs and whether impaired metabolism contributes to aging phenotypes in the SEZ. The findings that NSPCs derived from forebrain of middle-aged rodents display profound mitochondrial dysfunction (Stoll et al., 2011 and this study) and that genetically induced enhancement of mitochondrial biogenesis promotes generation of new neurons in the SEZ of aged mice (Stoll et al., 2015) , however, suggest that mitochondrial dysfunction is also a significant contributor to age-associated impairment of neurogenesis in the SEZ/olfactory bulb system.
We found short-term piracetam treatment of aged animals to be sufficient to promote neurogenesis, suggesting mitochondrial metabolism as a potential pharmacological target to ameliorate age-associated hippocampal neurogenesis deficits. Lineage progression analysis suggested that piracetam may enhance neurogenesis already at the stage of stem cell activation. This observation appears to contradict the notion that ETC and oxPhos function are critical at the stage of IPCs. Piracetam improves different sets of mitochondrial parameters in compromised cells depending on the experimental context (Figures 5A-5C and S5; Costa et al., 2013; Keil et al., 2006; Kurz et al., 2010; Leuner et al., 2010; Stockburger et al., 2013; Zhang et al., 2010) , suggesting that piracetam impacts on a number of pathways in mitochondria. As the function of metabolic pathways in stem cell and neurogenesis regulation is only beginning to unfold, one cannot exclude the possibility that piracetam promoted NSC activation through a critical mitochondrial pathway other than ETC or oxPhos. The systemic administration of piracetam may have also affected the function of neurogenic niche cells, which are providing key regulatory signals in hippocampal neurogenesis (Aimone et al., 2014) . Supporting this notion are our observations that piracetam resulted in a more homogeneous expression of mitochondrial complexes throughout the DG and that piracetam had a more robust effect on proliferation in vivo than on proliferation in vitro. A detailed understanding of the critical mitochondrial metabolic circuits in adult neurogenesis and of the impact of aging on mitochondrial dysfunction in the neurogenic lineage and the neurogenic niche could support the development of novel strategies to ameliorate neurogenesis-dependent cognitive deficits in aging.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (Table S1 ). Data represented as mean ± SEM; t test was performed to determine significance; scale bars = 10 mm (E) and 20 mm (F and G). 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Dr. Chichung Lie (chi.lie@ fau.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All experiments were carried out in accordance with the European Communities Council Directive (86/609/EEC). Animal experiments were approved by the Governments of Upper Bavaria, Middle-Franconia, and Hesse.
For all experiments, mice were group housed in standard cages under a 12 hr light/dark cycle with ad libitum access to water and food. Tfam loxP/loxP mice (Larsson et al., 1998) , GLAST::CreER T2 (Mori et al., 2006) , CAG-CAT-EGFP reporter mice (Nakamura et al., 2006) , and hGFAPeGFP (Nolte et al., 2001 ) served for the characterization of in vivo phenotypes and in vitro studies. For EM-studies, Nestin-GFP mice (Yamaguchi et al., 2000) and C57BL/6 (Charles River, Sulzfeld, Germany) were used. For piracetam experiments, we injected NMRI mice (Charles River, Sulzfeld, Germany). All animals have been described previously.
METHOD DETAILS
Tissue processing Animals were sacrificed using CO 2 . Mice were transcardially perfused with 50 mL phosphate-buffered saline (PBS, pH 7.4) followed by 100 mL 4% paraformaldehyde (PFA) at a rate of 10 mL/min. Brains were postfixed in 4% PFA for 12 hr at 4 C and were subsequently transferred to a 30% sucrose solution. Coronal brain sections were produced using a sliding microtome (Leica Microsystems, Wetzlar, Germany) for phenotyping and morphological analysis.
Tfam genotyping
The following primers were used for genotyping 
EM processing
To analyze NSCs of the dorsal dentate gyrus, tissue from transgenic Nestin-GFP mice was processed as previously described (Moss et al., 2016) . Briefly, male mice (P83-88) were anaesthetised, transcardially perfused with phosphate-buffered saline (PBS) then fixative, and placed at 4 C for 24 hr. Brains were post-fixed for 24 hr at 4 C, washed in PBS, and cut in 50 mm coronal sections. Sections were washed in PBS, incubated in cryoprotectant (2 h; room temperature; r.t.), freeze-thawed and Nestin-GFP revealed with immuno-peroxidase or -gold.
For the immunoperoxidase (IP) processing, an overnight incubation (r.t.) with a rabbit anti-GFP primary antibody (1:1000; Invitrogen) was followed by 2 hr incubation (r.t) in a secondary antibody (biotinylated goat anti-rabbit; 1:200; Jackson Laboratories). Incubation in avidin biotin peroxidase complex (ABC Elite; Vector Laboratories; 90 min; r.t.) and washes in 0.05 M Tris-buffered saline (Sigma) preceded the peroxidase reaction with 3, 3-diaminobenzidine as the chromogen (DAB; Vector Laboratories Kit; 4-6 min reaction).
For the immunogold (IG) processing, the sections were incubated overnight (r.t.) in the primary antibody (rabbit anti-GFP; 1:1000; Invitrogen) and for 2 hr (r.t.) in the gold-conjugated secondary antibody (goat anti-rabbit; 1:100; Nanoprobes; 1.4 nm colloidal gold). Sections were then washed in PBS and 0.1 M sodium acetate 3-hydrate buffer (Sigma), before the gold particles were silver intensified (HQ Silver Kit; Nanoprobes; 3-5 min).
To analyze IPCs, C57BL/6 female mice (P56-70) were stereotaxically injected with a recombinant MML-retrovirus encoding for GFP (pCAG-GFP), as previously described . Two days after injection, mice were transcardially perfuse-fixed and their brains IP processed (as for NSC tissue) to reveal GFP labeling of IPCs for EM. In place of primary and secondary antibodies, a biotinylated primary antibody was used to improve labeling efficacy (biotinylated rabbit anti-GFP, Vector Laboratories, 1:1000).
Both IP-and IG-labeled sections, containing NSCs or IPCs, were then prepared for EM. Sections were post-fixed with 1% osmium tetroxide (Electron Microscopy Sciences; 30 min for IP-labeling, 7 min for IG-labeling), and then dehydrated in an ascending series of ethanol dilutions [50%, 70% (with 1% uranyl acetate; w/v; Electron Microscopy Sciences), 95% and 100%] and acetone. Sections were then lifted into resin (Durcupan ACM, Fluka), left overnight (r.t.), then placed on microscope slides, coverslipped, and the resin cured at 65 C for 3 d. Regions of interest were identified at the light microscope level, then tissue was cut from the slide and serial ultrathin sections (70 nm) were cut and collected onto Formvar-coated, single-slot copper grids (Electron Microscopy Sciences). The tissue was then contrasted with lead citrate and examined using a Philips CM10 transmission electron microscope (Electron Microscope Facility at the University of Lausanne). Images were captured using a digital camera (Morada SIS, Olympus), processed using Adobe Creative Suite and analyzed/3D-reconstructed using Fiji ImageJ software.
To analyze newborn neurons, MML-retroviral birthdating using the pCAG-GFP vector was used . Briefly, adult C57BL/6 female mice (30 d after viral injection at P4) were perfused with saline then PBS-containing fixative, and their brains cut in 100 mm coronal sections. Under a fluorescence microscope, 1-2 cells per mouse were injected with 5% aqueous Lucifer yellow (Sigma). Sections were incubated with 2.8 mM DAB and 6 mM potassium cyanide, and irradiated under epifluorescence using a 75-W Hg to induce photo-conversion of DAB into an electron-dense residue. Sections were then post-fixed overnight in a solution of 3% glutaraldehyde and processed for electron microscopy as for NSC/IPC tissue. Serial sections of labeled dendritic segments were cut longitudinally at a thickness of 40 nm and imaged with a Megaview III camera mounted on a JEOL 100CXII electron microscope. Images were processed using Adobe Photoshop, aligned using Align software (J. Fiala, Boston University) and analyzed/3D-reconstructed using Fiji ImageJ.
In vitro assays
Neural stem/progenitor cell (NSPC) isolation NSPCs were isolated from the DG of 8 weeks-old Tfam fl/fl mice and from the forebrain of 4 months and 1 year-old hGFAPeGFP mice with the MACS neural tissue dissociation kit according to manufacturer's protocol (MACS Miltenyi Biotec). Cells were kept in proliferative growth medium consisting of DMEM F12 Glutamax (GIBCO) medium with 1xNeurobrew-21 (MACS Miltenyi Biotec), 1xPSF (GIBCO) 8 mM HEPES and 10 ng/ml EGF and 10 ng/ml FGF (Peprotech) and were grown as neurospheres.
KO induction of Tfam loxP/loxP cells
Tfam loxP/loxP NSPCs were grown as neurospheres, dissociated with Accutase (Millipore) into single cells. Two million cells were seeded in 10 mL growth medium on 10 cm tissue culture plates coated with PDL/Laminin. After 24 hr cells were transduced with a GFP encoding control MML-retrovirus or a MML-retrovirus bi-cistronically encoding for Cre recombinase and GFP. Transduction was repeated 3 days later. Cells were harvested the next day and subsequently used in experiments. Recombination was confirmed via genotyping PCR. BMP4-treatment NSPCs were grown as neurospheres, dissociated with Accutase (Millipore) into single cells and seeded according to experiments. After 3 hr cells were treated with 20 ng/ml BMP4 (R&D Systems). Experiments were started 24 hr after exposure to BMP4. Treatment with Rotenon, Oligomycin and piracetam NSPCs were grown as neurospheres, dissociated with Accutase (Millipore) into single cells and seeded on PDL/Laminin coated tissue culture plates. Seeding densities are listed in the respective experiments. After 24 hr cells were incubated with either 1 mM Rotenon, 3.8 mM Oligomycin, and/or 1 mM piracetam for 24 hr prior to analysis. Mitochondrial Membrane Potential Measurement NSPCs were dissociated with Accutase into single cells and were seeded in 0.5 mL of growth medium at a density of 200,000 cells/ well onto a 24-well tissue culture plate coated with PDL/Laminin. After 24 hr cells were treated as indicated. 24 hr later 0.4 M Rhodamin-123 was added for 15 min at 37 C. 500 ml HBSS was added and the plate was centrifuged at 1500 rpm for 5 min. Supernatant was removed, 500 ml HBSS was added and the fluorescence signal was measured using aVICTORX2Multilabel Plate Reader (Perkin Elmer) at 490/535 nm. The transmembrane distribution of the Rhodamin-123 dye is proportional to strength of the membrane potential. ATP Measurement ATP levels were determined using a bioluminescence Assay (ViaLight PlusÒ Kit). The assay is based on a luciferase reaction, which catalyzes the formation of light from ATP and luciferin. NSPCs were dissociated with Accutase into single cells. Cells were seeded in 100 ml of growth medium at a density of 40,000 cells/well onto a white-walled 96 well plate coated with PDL/Laminin. After 24 hr cells were treated as indicated. 24 hr later cells were processed according to the manufacturer's instructions. The emitted light, which is linearly proportional to the ATP concentration, was measured with a VICTOR X2 Multilabel Plate Reader (Perkin Elmer). Amount of ATP per 40,000 cells was determined by interpolation according to an ATP standard. Proliferation Assay NSPCs were dissociated with Accutase into single cells. Cells were seeded in 1 mL growth medium at a density of 100,000 cells / well onto a 24-well tissue culture plate coated with PDL/Laminin. 24 hr later, cells were treated with 5 mM BrdU for 2 hr prior to fixation with 4% PFA. Immunocytochemistry was performed as previously described (Lie et al., 2002) . All quantifications were performed in a blinded fashion. Viability Assay NSPCs were dissociated with Accutase into single cells, seeded in 1 mL growth medium at a density of 50,000 cells/well onto a 24-well tissue culture plate, and treated as indicated. 24 hr later, 15 ml of the cell suspension were mixed with 15 ml of Trypan blue. The number of dead and living cells was determined under a fluorescent microscope with a Neubauer counting chamber and the cell death rate was calculated as the ratio of dead cells per total number of cells (dead + living cells). All quantifications were performed in a blinded fashion.
Histology and counting procedures
The following primary antibodies were used: mouse anti-Cox1 (MTCO1) (1:500; Abcam), goat anti-HSP60 (1:500; Santa Cruz), mouse anti-mitochondrial complexes I-V (oxPhos) mix ( Primary antibodies were visualized with Fluorophore-conjugated secondary antibodies (all 1:400; see Key Resource Table) . Biotinylated secondary antibodies (1:400; see Key Resource Table) were used in combination with Fluorophore-conjugated to Streptavidin (1:400; see Key Resource Table) to enhance the signal of GFP, HSP60, Cox1 and mitochondrial complex I-V mix. As a negative control, staining was done using secondary antibody only.
Immunofluorescent stainings were performed on free-floating 40 and 50 mm sections. Slices were washed 3 times with PBS and incubated with primary antibodies in PBS containing 0.5% Triton X-100 and 10% normal donkey serum (NDS) for 72 hr at 4 C. After incubation with the primary antibody, tissue was thoroughly washed with PBS at room temperature and subsequently incubated with the secondary antibody in PBS containing 0.5% Triton X-100 and 10% NDS overnight at 4 C or 2 hr at room temperature. After washing thoroughly in PBS, nuclei were stained with DAPI and sections were mounted on coverslips with Aqua poly mount (Polysciences).
For BrdU staining, tissue was pre-treated in 2M HCL for 30 min, washed shortly in PBS, incubated in Borate buffer (0.1 M, pH 8.5) two times for 15 min, followed by washing with PBS before adding the BrdU antibody.
For immunostainings against mitochondrial markers Cox1, HSP60, and mitochondrial complexes I-V mix, sections were subjected to antigen retrieval. Slices were incubated in Tris-EDTA/Tween20 for 5 min at 99 C and washed 3 times with MilliQ water followed by one washing step with PBS prior incubation with primary antibody.
Confocal single plane images and Z stacks were taken at the Zeiss LSM 780 with four lasers (405, 488, 559, and 633nm) and 63x objective lens and Leica SP5 equipped with four laser lines (405, 488, 559 and 633nm) and 63x and 40x objective lens. Images were processed using using Fiji ImageJ. 3D reconstructions were obtained by using Imaris software (Bitplane AG, Z€ urich, Switzerland).
Cell death analysis
ApopTag Red in Situ Apoptose Detection Kit (Millipore) was used for cell death anaylsis. Free floating sections from ctrl and Tfam cko mice were processed according to the manufacturer's protocol of fluorescent staining of tissue cryosections.
BrdU administration
For proliferation and survival studies, animals were intraperitoneally injected with a single dose of Bromodeoxyuridine (BrdU, 50 mg/kg body weight, Sigma-Aldrich) per day. BrdU was dissolved in 0.9% NaCl and sterile filtered.
To measure proliferation in 4 month-old Tfam cko and control mice, mice received a single dose of BrdU 3h prior to perfusion. To compare proliferation between young (4 month-old) and middle-aged (one year-old) mice, mice received daily injections of BrdU for seven consecutive days and were sacrificed 2h after the last injection.
Piracetam administration
Eighteen month-old wild-type NMRI mice received freshly prepared piracetam (2-oxo-1-pyrrolidine-acetamide; 500 mg/kg body weight) administered by gavaging once per day for 14 consecutive days. Control mice (18 month-old wild-type NMRI) received a comparable amount of water by gavage. Animals were perfused one day after the last administration.
Retrovirus preparation and stereotactic injections MML-retroviruses were generated as previously described (Tashiro et al., 2006) . Viral titers were approximately 2x10 8 colony-forming units (cfu) ml -1 . 8 week-old Tfam loxP/loxP mice were stereotactically injected with the pCAG-GFP-IRES-Cre retrovirus to induce recombination of the conditional Tfam locus in highly proliferative precursors of the DG. 8 week-old Tfam loxP/loxP mice injected with the pCAG-GFP retrovirus served as controls. The pCAG-GFP retrovirus was also used to birthdate and label newborn neurons for morphology analysis in 2 month-and 8 month-old C57/Bl6 mice. For stereotactic injections, mice were deeply anesthetized by injecting Fentanyl (0.05 mg/kg; Janssen-Cilag AG, New Brunswick, USA), Midazolam (5 mg/kg; Dormicum, Hoffmann-La Roche, Basel, Switzerland) and Medetomidine (0.5 mg/kg; Domitor, Pfizer Inc., New York, USA) dissolved in 0.9% NaCl. Mice were stereotactically injected with 0.9 ml the retroviruses with a titer of 1 3 10 8 cfu 3 ml -1 into the left and right dentate gyrus (coordinates from bregma were À1.9 anterior/posterior, ± 1.6 medial/lateral, À1.9 dorsal/ventral from dura). Anesthesia was antagonized by injecting Buprenorphine (0.1 mg/kg, Temgesic, Essex Pharma GmbH, Munich, Germany), Atipamezol (2.5 mg/kg; Antisedan, Pfizer Inc., New York, USA) and Flumazenil (0.5 mg/kg; Anexate, Hexal AG, Holzkirchen, Germany) dissolved in 0.9% NaCl.
QUANTIFICATION AND STATISTICAL ANALYSIS EM mitochondrial volume analyses
Using the serial EM images collected, mitochondrial volumes were analyzed for NSC cell bodies (29 mitochondria, from 2 cells of 2 animals), NSC primary processes (36 mitochondria, 3 cells, 3 animals), NSC fine processes (36 mitochondria, 6 cells, 5 animals), IPC cell bodies (20 mitochondria, 2 cells, 1 animal), IPC primary processes (20 mitochondria, 1 cell, 1 animal) and nb neuron dendrites (30 mitochondria, 4 cells, 4 animals). Mean volumes were calculated and expressed ± SEM (standard error of the mean), and compared using a One-Way ANOVA and post hoc Tukey's Test (F (5, 164) = 12.02, p < 0.0001).
Analysis of transcriptomic resource
A detailed description of the resource describing the transcriptomic dynamics of early adult hippocampal neurogenesis is provided in the publication by Shin and colleagues (Shin et al., 2015) . For functional gene expression analysis, we first divided the entire transcriptome into three equal number of groups based on their Spearman correlation to pseudotime: positively correlated genes, no correlated genes, and negatively correlated genes. We then evaluated the proportion of positively correlated genes versus negatively correlated genes within each functional entity from an independent functional annotation database called wikipathway (Pico et al., 2008) . If a functional entity contained disproportionally larger number of upregulated genes than downregulated genes, we could assume that the functional entity is generally activated during early neurogenesis. In contrast, if a GO term contained disproportionally larger number of downregulated genes than upregulated genes, we could assume the pathway is generally inactivated during early neurogenesis. We used custom R code to apply Hidden Markov model (HMM) to predict gene expression states throughout pseudotime. Briefly, we divided pseudotime into 40 bins, each of which contains average 2.5 single cells. We averaged the expression level within each bin and assigned the expression values to observed variables for HMM. We used Baum-Welch algorithm to extract most probable emission probabilities and transition probabilities without inputting any arbitrary parameters. Using the output from Baum-Welch algorithm along with the observed variables, we applied Viterbi algorithm to predict the hidden gene expression states.
Expression analysis of stage-specific markers
Stage-specific marker expression (Nestin, MCM2, Tbr2, DCX, Prox1, GFAP etc. > 50 cells/per animal and marker) was analyzed by confocal microscopy in at least four sections containing the dentate gyrus from n = 3-7 different animals (as indicated in the figure legends, and in Table S1 ).
All quantifications were done in a blinded fashion. In the in vivo piracetam experiment, one piracetam-treated animal was excluded from the analysis of DCX marker expression (Figure 5K) because of a lack of reproducible DCX immunostaining.
Dendritic morphology analyses
To analyze dendrite morphology, confocal images of transduced cells expressing GFP or of cells stained against DCX (for Piracetam experiments) were obtained with a 63 3 glycerol objective using a Leica TCS Sp5 confocal microscope (Leica Microsystems, Wetzlar, Germany) (step size 0.3 mm, resolution 1024 3 1024). For the analysis of dendrite morphology in Tfam cko mice, 100 mm thick sections were used. For the comparative retrovirus-based analysis of dendrite morphology in young and middle-aged mice, 60 mm thick sections were used. For the DCX-based analysis of dendrite morphology in the piracetam experiment, 40 mm thick sections from a comparable hippocampal position were used. 14-26 cells per group from at least 3 different animals were analyzed. 3D reconstructions were obtained by using the Filament Tracer tool in Imaris (Bitplane AG, Z€ urich, Switzerland), and values for total dendritic length, number of branch points and number of Scholl intersections were determined.
All quantifications were done in a blinded fashion.
Statistical analysis
Significance levels were assessed using unpaired Student's t test with unequal variances; for quantification of mitochondrial volume we applied One-Way ANOVA with post hoc Tukey's multiple comparisons test to determine significance. Differences were considered statistically significant at *p < 0.05, **p < 0.01 and ***p < 0.001. All data are presented as mean ± SEM (standard error of the mean).
DATA AND SOFTWARE AVAILABLILTY
Custom R code to apply Hidden Markov model (HMM) to predict gene expression states throughout pseudotime can be found online at http://dx.doi.org/10.1016/j.stem.2015.07.013 in Data S1 (Shin et al., 2015) .
